Stockscreener 앱 받기
2.61
6.79%
-0.19
시간 외 거래:
2.64
0.03
+1.15%
전일 마감가:
$2.80
열려 있는:
$2.7
하루 거래량:
91,661
Relative Volume:
0.26
시가총액:
$3.91M
수익:
-
순이익/손실:
$-6.78M
주가수익비율:
-0.0611
EPS:
-42.6996
순현금흐름:
$-4.67M
1주 성능:
-9.00%
1개월 성능:
-69.85%
6개월 성능:
-92.41%
1년 성능:
-94.33%
1일 변동 폭
$2.4001
$2.8399
1주일 범위
$2.36
$3.2499
52주 변동 폭
$2.36
$87.20
Clearmind Medicine Inc Stock (CMND) Company Profile
CMND을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CMND
Clearmind Medicine Inc
|
2.61 | 4.20M | 0 | -6.78M | -4.67M | -42.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
447.38 | 114.05B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
748.71 | 78.80B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
396.04 | 51.80B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
847.05 | 53.08B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
166.55 | 42.33B | 447.02M | -1.18B | -906.14M | -6.1812 |
Clearmind Medicine Inc 주식(CMND)의 최신 뉴스
Psychedelic: Clearmind completes second cohort enrollment for CMND-100 trial - TipRanks
How interest rate cuts could boost Clearmind Medicine Inc. stockEarnings Growth Summary & Low Risk High Win Rate Picks - Улправда
Is Clearmind Medicine Inc. stock a top momentum playJuly 2025 Summary & Community Verified Trade Signals - Улправда
Why retail traders accumulate Clearmind Medicine Inc. (CWY0) stockJuly 2025 Trends & AI Enhanced Trading Alerts - Bollywood Helpline
Sentiment Review: How Clearmind Medicine Inc CWY0 stock reacts to monetary easingJuly 2025 Setups & Weekly High Potential Alerts - moha.gov.vn
Clearmind Medicine completes second cohort enrollment in Phase I/IIa AUD trial - TipRanks
Clearmind Medicine announces successful completion of second cohort enrollment - marketscreener.com
Clearmind completes enrollment for second AUD treatment trial cohort - Investing.com
Clearmind completes enrollment for second AUD treatment trial cohort By Investing.com - Investing.com South Africa
Clearmind Medicine Inc. Announces Successful Enrollment of Second Patient Cohort in Phase I/IIa Trial for CMND-100 to Treat Alcohol Use Disorder - Quiver Quantitative
Clearmind Medicine Announces Successful Completion of Second Cohort Enrollment in Ongoing FDA-Approved Phase I/IIa Trial for CMND-100 - marketscreener.com
Clearmind Medicine announces receipt of Nasdaq minimum bid price notification - MSN
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com
Clearmind Medicine's MEAI Spotlighted in Prestigious Review: Leading Experts Affirm Transformative Potential for Alcohol Use Disorder Treatment - The Manila Times
Clearmind Medicine Regains Compliance With Nasdaq's Minimum Stockholders' Equity Requirement - marketscreener.com
Clearmind Medicine Successfully Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement - The Manila Times
Clearmind Medicine regains compliance with Nasdaq listing rule By Investing.com - Investing.com Canada
Clearmind regains compliance with Nasdaq minimum equity rule - Investing.com
Clearmind Medicine regains compliance with Nasdaq listing rule - Investing.com
Clearmind Medicine Inc. Regains Compliance with Nasdaq Listing Rule on Minimum Stockholders’ Equity - Quiver Quantitative
Clearmind Medicine Successfully Regains Compliance with Nasdaq's Minimum ... | Associated Press | syndication news - Enidnews.com
Clearmind Medicine To Implement 1-for-40 Reverse Stock Split Next Week - Nasdaq
Why Did Clearmind Medicine Shares Plunge 29% After Hours? - Benzinga
Clearmind Medicine to enact 1-for-40 reverse share split; shares down - MSN
Clearmind Medicine to implement 1-for-40 reverse stock split - Investing.com India
Clearmind Medicine to implement 1-for-40 reverse stock split By Investing.com - Investing.com Australia
Clearmind Medicine Inc. Announces 1-for-40 Reverse Share Split to Regain Nasdaq Compliance - Quiver Quantitative
Clearmind Medicine Announces 1-for-40 Reverse Share Split - The Manila Times
Clearmind Medicine Announces 1-for-40 Reverse Share Split | Associated Press | syndication news - Enidnews.com
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Clearmind Medicine Announces Receipt of Nasdaq Minimum Bid Price Notification - marketscreener.com
Clearmind Medicine Shares Surge After Securing Final Approval for AUD Drug Trial Site - MSN
Clearmind Medicine reports regaining Nasdaq equity compliance after financings - Investing.com
Clearmind Medicine reports regaining Nasdaq equity compliance after financings By Investing.com - Investing.com Australia
Clearmind Medicine Inc. Receives Nasdaq Compliance Notice Regarding Minimum Bid Price Requirement - Quiver Quantitative
Clearmind Medicine stock drops after Nasdaq compliance notice By Investing.com - Investing.com South Africa
Clearmind Medicine stock drops after Nasdaq compliance notice - Investing.com India
Is Clearmind Medicine Inc. stock near bottom after declineWeekly Loss Report & High Return Stock Watch Alerts - Newser
Will Clearmind Medicine Inc. stock outperform tech sector in 2025July 2025 Catalysts & Safe Investment Capital Preservation Plans - Newser
How Clearmind Medicine Inc. (CWY0) stock behaves under inflation pressureWeekly Gains Report & Low Risk Entry Point Tips - Newser
Clearmind Medicine Inc files for offering of up to 16 million common sharesSEC filing - marketscreener.com
What MACD trends signal for Clearmind Medicine Inc. (CWY0) stock - Newser
Is Clearmind Medicine Inc. (CWY0) stock a good hedge against inflationJuly 2025 Levels & Risk Managed Investment Signals - Newser
Can Clearmind Medicine Inc. (CWY0) stock double in coming yearsJuly 2025 Earnings & Verified High Yield Trade Plans - Newser
Clearmind enrolls first participant in AUD trial at Hadassah Medical - Investing.com India
Clearmind Medicine Inc (CMND) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.31%
0.33%
자본화:
|
볼륨(24시간):